Home
About The Penn Lung center
Contact Us

Pulminary, Allergy, and Clinical Care Division
Pulminary and Critical Care
Healthcare
Research
Psysicians and Staff
Faculty
Fellows
Nursing
Administrative Staff
Education
Intranet
Allergy and Immunology
Thoriatic Survey Division
Lung Pathology Division
Chest Radiology Division
CT Anestesia Division
Affiliated Centers and Institutes

PennHealth.com

Harold Palevsky, M.D.

Professor of Medicine
Chief, Pulmonary, Allergy and Critical Care Division
Director, Pulmonary Vascular Disease Program
Penn Presbyterian Medical Center
Director, Pulmonary Vascular Disease Program
University of Pennsylvania Health System

University of Pennsylvania Medical Center
Pulmonary, Allergy & Critical Care Division
120 PHI Building
Presbyterian Medical Center
51 N. 39th Street
Philadelphia, PA 19104
tel.: (215) 662-8585
fax.: (215) 243-4643
email: harold.palevsky@uphs.upenn.edu

Education:

  • MD: Medical College of Virginia
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Dr. Palevsky heads the Pulmonary Vascular Disease Program, a multi-disciplinary program focusing on the diagnosis and treatment of pulmonary vascular disease and focusing on pulmonary arterial hypertension and pulmonary thromboembolic disease, both acute and chronic. The program offers state of the art diagnostic techniques, both non-invasive and interventional, and multi-modality treatments including all approved agents, several investigational agents and, when appropriate, surgical procedures, including pulmonary thromboendartectomy and lung transplantation.

Representative Publications:

Meyer, N.J. and  Palevsky, HI.  Deep venous thrombosis and pulmonary embolism.  In:  The Intensive Care Unit Manual, 2nd Edition, edited by P.N. Lanken, C.W. Hanson, and S. Manaker, New York, W.B. Saunders, 2009, pp. (in press)

John, J. and Palevsky, H.I.  Pulmonary arterial hypertension.    In:  Principles of Pulmonary Protection During Heart Surgery, edited by E. A. Gabriel and T. Salerno.   Springer, (in press)

Kawut, S.M. and Palevsky, H.I.  Combination therapy for pulmonary arterial hypertension. In:  Pulmonary Circulation:  Diseases and Their Treatments.  Third Edition., edited by A.J. Peacock, R. Naeije, L.J. Rubin.  London.  Chapman & Hall Medical.  (in press)

Zlupko, M., Harhay, M.O., Gallop, R., Shin, J., Archer-Chicko, C., Patel, R., Palevsky, H.I., and Taichman, D.B.:  Evaluation of Disease-Specific Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.  Respiratory Medicine 102(10):1431-1438, 2008.

Thenappan T. and Palevsky, H.I.: Long-term Out comes in Pulmonary Arterial Hypertension.  International Journal of Clinical Practice.  63 (suppl 162):42-44, 2009.

Taichman, D.B., McGoon, M.D., Harhay, M.O., Archer-Chicko, C, Sager, J.S., Murugappan, M., Chakinalli, M.M., Palevsky, H.I., Gallop, R.:  Wide variation in clinicians’ assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension.  Mayo Clin Proc 84:586-592, 2009.

Palevsky, HI. Guest Editor, Clinics in Chest Medicine, Pulmonary Arterial Hypertension, Volume 28 (1), March 2007
Alam, S and Palevsky, HI.  Standard therapies for pulmonary arterial hypertension.  Clin Chest Med, 28:91-115, 2007.

Alam, S and Palevsky, HI.  Pulmonary hypertension and acute right heart failure.  In Respiratory Emergencies, Edited by A. Fein, S Kamholz, and D. Ost, London, Hodder Arnold, 2006, pp. 375-403.

Palevsky, HI. Thromboembolic disease. In Pulmonary and Respiratory Therapy Secrets, 3rd Edition, edited by P.E. Parsons and J.E. Heffner, Mosby/Elsevier Inc., Philadelphia, PA, pp. 269-284, 2006.

Friedman, E., Palevsky, H.I., and Taichman D.B.: Classification and Prognosis of Pulmonary Arterial Hypertension. In Pulmonary Vascular Disease, edited by J. Mandel and D.B. Taichman. Saunders/Elsevier Inc., Philadelphia, PA, pp 66-82, 2006.

Archer-Chicko, C, Housten-Harris, T, Palevsky, HI. Practical nursing issues in the outpatient management of pulmonary vascular disease. In Pulmonary Vascular Disease, edited by J. Mandel and D.B. Taichman,. Saunders/Elsevier Inc., Philadelphia, PA, pp 314-329, 2006.

Taichman, DB, Palevsky, HI. Treatment of pulmonary arterial hypertension with the endothelin receptor antagonist bosentan. Clin Pulmonary Medicine 12(2): 121-127, 2005.

Kawut, S. M., Taichman, D.B., Ahya, V. N., Kaplan Sandra, Archer-Chicko, C.L. Kimmel, S. E. Palevsky, H. I.: Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transplantation 11(9):1107-11, 2005.

Taichman, D.B., Shin, J., Hud, L., Archer-Chicko, C., Kaplan, S., Sager, J.S., Gallop, R., Christie, J., Hansen-Flaschen, J. and Palevsky, H.I.: Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res Vol. 6: 92, 2005.

Kawut, SM, Palevsky, HI. Surrogate end points for pulmonary arterial hypertension. Am Heart J. 148:559-565, 2004.

Elliott, CG, Palevsky, HI, Treatment with Epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis. Thorax 59:536-537, 2004.

Kawut, SM, Taichman, DB, Archer-Chicko, CL, Palevsky, HI and Kimmel, SE. Hemodynamics and survival in pulmonary arterial hypertension related to systemic sclerosis. Chest, 123:344-350, 2003.

revised 9/09



Go back to Faculty listing page.


University of Pennsylvania Health System